share_log

4: Statement of changes in beneficial ownership of securities-Director McMullen Michael R.

4: Statement of changes in beneficial ownership of securities-Director McMullen Michael R.

4：持股變動聲明-董事 McMullen Michael R.
美股sec公告 ·  07/02 17:37
Moomoo AI 已提取核心訊息
Michael R. McMullen, associated with Bristol-Myers Squibb Co. [BMY], was involved in a transaction on 07/01/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. As such, the impact of this event on McMullen's holdings and the overall market position of Bristol-Myers Squibb remains unclear.
Michael R. McMullen, associated with Bristol-Myers Squibb Co. [BMY], was involved in a transaction on 07/01/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. As such, the impact of this event on McMullen's holdings and the overall market position of Bristol-Myers Squibb remains unclear.
與施貴寶公司[BMY]有關的Michael R. McMullen在2024年07月01日進行了一項交易。公告未披露該交易的具體細節，包括操作類型、狀態幣、涉及的股份數量、股份性質、交易價格和發帖後持股情況。因此，這一事件對於McMullen的持股和施貴寶的整體市場地位的影響仍不清楚。
與施貴寶公司[BMY]有關的Michael R. McMullen在2024年07月01日進行了一項交易。公告未披露該交易的具體細節，包括操作類型、狀態幣、涉及的股份數量、股份性質、交易價格和發帖後持股情況。因此，這一事件對於McMullen的持股和施貴寶的整體市場地位的影響仍不清楚。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息